Inspiralis Limited has been supplying topoisomerase products to the pharmaceutical industries and academia for over 10 years under its former name of John Innes Enterprises.
Building on this extensive platform of experience the company has been formed to further develop links with research groups worldwide to enhance their understanding of infectious disease and cancer. It has received the financial backing of a team of investors who have provided the seed funds to enable the company to move to new labs within the Norwich Bioincubator.
Our directors and scientific staff have impressive publication records and bring to the company many years of experience working within the topoisomerase field. They can provide high quality products produced by experienced scientists combined with highly personalised technical support from research labs working closely with the company.
Tony Maxwell – Non-Executive Director and Founder
Nicolas Burton – Director and Founder
Alison Howells – Director and Founder
Tony Blake – Non-Executive Director
Inspiralis Limited, Registered Office:
Norwich Research Park
Company Number 5837417